Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2019 | 08-2018 | 08-2017 | 12-2016 | 08-2016 | |
| Operating Expenses | 3,210 | 2,344 | 233 | 30 | 30 |
| Operating Income | -3,210 | -2,344 | -233 | -30 | -30 |
| Interest Expense | 0 | 0 | 2 | 0 | 0 |
| Other Income | 1,037 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,172 | -2,344 | -235 | -30 | -30 |
| Net Income Continuous | -2,172 | -2,344 | -235 | -30 | -30 |
| Net Income | $-2,172 | $-2,344 | $-235 | $-30 | $-30 |
| EPS Basic Total Ops | -89.94 | -165.48 | -2.70 | N/A | 0.00 |
| EPS Basic Continuous Ops | -89.93 | -164.98 | -2.42 | N/A | -0.35 |
| EPS Diluted Total Ops | -89.94 | -165.48 | -2.70 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -89.93 | -164.98 | -2.42 | N/A | -0.35 |
| EBITDA(a) | $-3,209 | $-2,343 | $-232 | $-30 | $-30 |